USANA Health Sciences Positive Divergence On Large Players Volume

stocks-to-watch usna - USANA Health Sciences Positive Divergence On Large Players Volume

USANA Health Sciences’ stock has formed a positive divergence on large players volume. The price action has faded over the last couple of weeks into what could be a bullish flag channel. I bought some USANA Health Sciences in my personal trading account this morning.

The 3 month change in institutional ownership is +8.02% which suggests institutional traders are accumulating this stock.

Creative Planning increased its stake in USANA Health Sciences by a whopping 528% in Q2. Victory Capital increased its stake in USANA by 124.7% in Q1. Eqis Capital acquired a new position in USANA in the Q2 worth $210,000. Nine Chapters Capital acquired a new position in USANA in Q1 worth $207,000. KCG Holdings Inc. acquired a new position in USANA in Q1 worth $248,000. Institutional investors and hedge funds own 46.3% of the company’s stock.

On August 18, 2017, USANA announced that it would expand in four European countries beginning mid-year 2018. These four new markets constitute of Romania, Germany, Italy, and Spain.

USANA Health Sciences was recently honored by inclusion in Utah Business Magazine’s Fast 50 list. This year marks the 10th consecutive time the company has made the list of fastest growing companies in Utah. USANA finished ranked number 49 on the list.

You can find out more about USANA here.

USANA Health Sciences

USANA Health Sciences chart.

USNA has been falling since September 1, 2017 while large players volume has been rising which suggests large players are accumulating the stock at its current level. The Twiggs Money Flow is attempting to go positive. There is very little resistance above the current price.

We see reduced volatility while prices have been consolidating which has formed a momentum squeeze:

USANA Health Sciences chart shows a momentum squeeze.

USANA Health Sciences Review
2.8

Summary

Profitability

USANA Health Sciences (USNA) Return On Asserts of 18.41% is among the best returns of the industry. USNA outperforms 96% of its industry peers. The industry average Return On Assets is -41.76%. USNA has a Profit Margin of 9.47%. This is better than the industry average of -46.01%. USNA's Return On Equity of 25.21% is inline with the rest of the industry. The industry average Return On Equity is 30.94%. The Piotroski-F score of USNA is 6.00. This is a neutral score and indicates average health and profitability for USNA.

Valuation

With a Price/Earnings Ratio of 15, USNA is valued correctly. Compared to an average industry Price/Earning Ratio of 22.7, USNA is valued inline with its industry peers. With a Forward Price/Earnings Ratio of 13.3, USNA is valued correctly. USNA's PEG Ratio of 1.5 which compensates the Price/Earnings for growth, indicates a correct valuation of the company. With a price book ratio of 3.69, USNA is valued correctly. Compared to an average industry price book ratio of 3.95, USNA is valued inline with its industry peers.

Growth

Measured over the past 5 years, USNA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.65% on average per year. The Earnings Per Share has been growing slightly by 1.58% over the past year. Looking at the last year, USNA shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year. Measured over the past 5 years, USNA shows a small growth in Revenue. The Revenue has been growing by 9.46% on average per year.

USANA Health Sciences Revenue Growth

Health

A Current Ratio of 2.44 indicates that USNA has no problem at all paying its short term obligations. An Altman-Z score of 10.05 indicates that USNA is not in any danger for bankruptcy at the moment. When comparing the Altman-Z score to an average industry Current Ratio of 1.47, USNA is in better financial health than the average industry peer. A Quick Ratio of 1.93 indicates that USNA should not have too much problems paying its short term obligations. The Piotroski-F score of USNA is 6.00. This is a neutral score and indicates average health and profitability for USNA. When comparing the Current Ratio of USNA to the average industry Current Ratio of 4.65, USNA is less able to pay its short term obligations than its industry peers. Compared to an average industry Quick Ratio of 4.42, USNA is worse placed to pay its short term obligations than its industry peers. When comparing the Debt to Equity Ratio of USNA to the average industry Debt to Equity Ratio of 0.00, USNA required more debt to finance its operations than its industry peers.

Fundamental analysis provided by Chartmill. Get instant fundamental analysis on your favorite stocks here.

Sending
User Rating 0 (0 votes)
stocks-to-watch e5e8ad7a1d734248837d99941403233a?s=80&r=pg - USANA Health Sciences Positive Divergence On Large Players Volume
Follow me

Lance Jepsen

For ethical purposes, I try not to hold any position in any stock I profile on GuerillaStockTrading.com unless specifically stated in the article. Owner of GuerillaStockTrading.com. Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.
stocks-to-watch e5e8ad7a1d734248837d99941403233a?s=80&r=pg - USANA Health Sciences Positive Divergence On Large Players Volume
Follow me

Latest posts by Lance Jepsen

No questions found.

    Ask a Question

    Attach YouTube/Vimeo clip putting the URL in brackets: [https://youtu.be/Zkdf3kaso]

    Author: Lance Jepsen

    For ethical purposes, I try not to hold any position in any stock I profile on GuerillaStockTrading.com unless specifically stated in the article. Owner of GuerillaStockTrading.com. Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.